Legal Representation
Attorney
Robert B.G. Horowitz, Esq.
USPTO Deadlines
Next Deadline
2097 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-29)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 19, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 15, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 15, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 15, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 2, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development services in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye
Additional Information
Design Mark
The mark consists of the stylized blue text 'BEACON" above the stylized blue text "THERAPEUTICS". The letter "O" in the word "BEACON" is replaced by a circle design made up of six inward-pointing blue triangles.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"